1,614 Shares in Albemarle Co. (NYSE:ALB) Bought by Mosley Wealth Management

Mosley Wealth Management purchased a new position in Albemarle Co. (NYSE:ALBFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,614 shares of the specialty chemicals company’s stock, valued at approximately $233,000.

Several other large investors also recently bought and sold shares of the business. OLD Point Trust & Financial Services N A bought a new position in Albemarle during the fourth quarter valued at $295,000. Ossiam increased its position in Albemarle by 17.8% during the fourth quarter. Ossiam now owns 114,760 shares of the specialty chemicals company’s stock valued at $16,581,000 after acquiring an additional 17,338 shares during the last quarter. Stamos Capital Partners L.P. increased its position in Albemarle by 10.9% during the fourth quarter. Stamos Capital Partners L.P. now owns 5,910 shares of the specialty chemicals company’s stock valued at $854,000 after acquiring an additional 580 shares during the last quarter. Wealth Quarterback LLC increased its position in Albemarle by 18.8% during the fourth quarter. Wealth Quarterback LLC now owns 3,191 shares of the specialty chemicals company’s stock valued at $461,000 after acquiring an additional 506 shares during the last quarter. Finally, Schroder Investment Management Group increased its position in Albemarle by 8.6% during the fourth quarter. Schroder Investment Management Group now owns 283,612 shares of the specialty chemicals company’s stock valued at $40,976,000 after acquiring an additional 22,373 shares during the last quarter. Institutional investors own 92.87% of the company’s stock.

Insider Activity

In other news, SVP Mark Richard Mummert sold 843 shares of the company’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $135.53, for a total transaction of $114,251.79. Following the transaction, the senior vice president now owns 6,802 shares in the company, valued at $921,875.06. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CAO John Clarence Barichivich III sold 1,475 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $132.17, for a total value of $194,950.75. Following the transaction, the chief accounting officer now owns 4,743 shares in the company, valued at approximately $626,882.31. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Mark Richard Mummert sold 843 shares of the stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $135.53, for a total transaction of $114,251.79. Following the completion of the transaction, the senior vice president now owns 6,802 shares in the company, valued at approximately $921,875.06. The disclosure for this sale can be found here. Corporate insiders own 0.38% of the company’s stock.

Albemarle Stock Performance

ALB stock opened at $114.94 on Monday. The firm has a market cap of $13.51 billion, a price-to-earnings ratio of 41.80, a PEG ratio of 2.88 and a beta of 1.61. The firm has a 50-day simple moving average of $123.93 and a two-hundred day simple moving average of $125.87. Albemarle Co. has a one year low of $106.69 and a one year high of $247.44. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.91 and a current ratio of 2.84.

Albemarle (NYSE:ALBGet Free Report) last released its quarterly earnings results on Thursday, May 2nd. The specialty chemicals company reported $0.26 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.09). Albemarle had a net margin of 4.02% and a return on equity of 14.53%. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same period in the previous year, the company posted $10.32 earnings per share. The business’s quarterly revenue was down 47.3% compared to the same quarter last year. On average, equities analysts forecast that Albemarle Co. will post 2.49 EPS for the current fiscal year.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Friday, June 14th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 14th. This represents a $1.60 annualized dividend and a dividend yield of 1.39%. Albemarle’s dividend payout ratio (DPR) is currently 58.18%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Wells Fargo & Company boosted their target price on shares of Albemarle from $135.00 to $145.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Vertical Research lowered shares of Albemarle from a “buy” rating to a “hold” rating and set a $145.00 target price for the company. in a research note on Friday, March 8th. Wolfe Research assumed coverage on shares of Albemarle in a research note on Friday, March 1st. They set a “peer perform” rating for the company. UBS Group lowered their target price on shares of Albemarle from $137.00 to $125.00 and set a “neutral” rating for the company in a research note on Thursday, February 15th. Finally, Berenberg Bank raised shares of Albemarle from a “hold” rating to a “buy” rating and upped their price objective for the stock from $130.00 to $160.00 in a research note on Thursday, April 11th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $165.16.

Read Our Latest Stock Analysis on ALB

Albemarle Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Recommended Stories

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.